Predictors of residual disease in repeat excisions for lumpectomies with margins less than 0.1 cm

Clinical Breast Cancer

Volumn 6, Issue 2, 2005, Pages 169-172

  Rodriguez, Norma ^a   Diaz, Leslie K ^b   Wiley, Elizabeth L ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Division of Surgical Pathology   (United States)

Author keywords

Breast conservation; Ductal carcinoma in situ; Mammary carcinoma

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PARTIAL MASTECTOMY; PREDICTION; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TUMOR VOLUME;

EID: 22144490828     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2005.n.020     Document Type: Article

References (30)

1. Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993; 281:22-28.
2. Clarke DH, Martinez AA. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists, and radiation and medical oncologists. J Clin Oncol 1992; 10:474-483.
3. Kurtz JM. Factors influencing the risk of local recurrence in the breast. Eur J Cancer 1992; 28:660-666.
4. Luu HH, Otis CN, Reed WJ Jr, et al. The unsatisfactory margin breast cancer surgery. Am J Surg 1999; 178:362-366.
5. Millar EK, Leong AS. Significance and assessment of margin status in ductal carcinoma in situ of the breast. Adv Anat Pathol 2001; 8:338-344.
6. Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin 1998; 48:83-107.
7. Beck NE, Bradburn MJ, Vincenti AC, et al. Detection of residual disease following breast-conserving surgery. Br J Surg 1998; 85:1273-1276.
8. Smitt MS, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76:259-267.
9. Spivack B, Khanna MM, Tafra L, et al. Margin status and local recurrence after breast-conserving surgery. Arch Surg 1994; 129:952-956; discussion 956-957.
10. Wazer DE, Schmidt-Ullrich RK, Schmid CH, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys 1997; 38:291-299.
11. Wazer DE, Jabro G, Ruthazer R, et al. Extent of margin positivity as a predictor for local recurrence after breast-conserving irradiation. Radiat Oncol Investig 1999; 7:111-117.
12. Beron PJ, Horwitz EM, Martinez AA, et al. Pathologic and mammographic findings predicting the adequacy of tumor excision before breast conserving therapy. AJR Am J Roentgenol 1996; 167:1409-1414.
13. Boyages J, Recht A, Connolly JL, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990; 19:29-41.
14. DiBiase SJ, Komarnicky LT, Schwartz GF, et al. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998; 82:2212-2220.
15. Holland PA, Gandhi A, Knox WF, et al. The importance of complete excision in the prevention of local recurrence in ductal carcinoma in situ. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, 1997:189-193.
16. Lagios MD. Pathologic features related to local recurrence following lumpectomy and irradiation. Semin Surg Oncol 1992; 8:122-128.
17. Tartter PI, Bleiweiss IJ, Levchenko S. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg 1997; 185:268-273.
18. Guidi AJ, Connolly JL, Harris JR, et al. The relationship between shaved margin and inked margin status in breast excision specimens. Cancer 1997; 79:1568-1573.
19. Jimenez RE, Bongers S, Bouwman D, et al. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. Am J Surg Path 2000; 24:123-128.
20. Saarela AO, Paloneva TK, Rissanen TJ, et al. Determinants of positive histologic margins and residual tumor after lumpectomy for early breast cancer: a prospective study with special reference to touch preparation cytology. J Surg Oncol 1997; 66:248-253.
21. Wiley EL, Diaz LK, Badve S, et al. Effect of time interval on residual disease in breast cancer. Am J Surg Pathol 2003; 27:194-198.
22. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999; 85:616-628.
23. Gwin JL, Eisenberg BL, Hoffman JP et al. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg 1993; 218:729-734.
24. Macmillan RD, Purushotham AD, Mallon E, et al. Tumour bed positively predicts outcome after breast-conserving surgery. Br J Surg 1997; 84:1559-1562.
25. Silverstein MJ, Gierson ED, Colburn WJ, et al. Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 1994; 73:2985-2989.
26. Chan KC, Knox WF, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 2001; 91:9-16.
27. Holland R, Connolly J, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8:1130-1138.
28. Schnitt SJ, Connolly JL, Khettry U, et al. Pathologic findings on re-excision of the primary site in breast cancer patient considered for treatment by primary radiation therapy. Cancer 1987; 59:675-681.
29. Solin LJ, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductual carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer 1993; 71:2532-2542.
30. Schwartz GF, Patchefsky AS, Finklestein SD, et al. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment. Arch Surg 1989; 124:29-32.